Search Results 1351-1360 of 18618 for hepatitis

  1. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HBsAg] test and a positive anti-HBc ...

  2. Publications - Mohamed Elrefaei, M.D., Ph.D. - Mayo Clinic

    Elrefaei M, El-Sheikh N, Kamal K, Cao H. HCV-specific CD27- CD28- memory T cells are depleted in hepatitis C virus and Schistosoma mansoni co-infection.

  3. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...

  4. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... hepatitis C;; Serologic status reflecting active hepatitis B or C infection. Patients with hepatitis B or C infection may be eligible if viral loads are ...

  5. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma - Mayo Clinic

    Hepatitis B (HBV): All subjects must be screened for hepatitis B and C. Subjects with a positive polymerase chain reaction for hepatitis B must be on ...

  6. Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis - Mayo Clinic

    Autoimmune hepatitis;; Wilson's disease, hemochromatosis, or iron overload;; Alpha-1 antitrypsin (A1AT) deficiency. Females who are pregnant or breastfeeding ...

  7. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    Active hepatitis B or hepatitis C; Prior treatment with CD137 agonists or immune checkpoint blockade therapies, anti PD1, and anti-PD-L1 therapeutic antibody ...

  8. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    ... hepatitis B virus (HBV) with positive hepatitis surface antigen (HBsAg +). Patients with a prior history of HBV infection, but immune, with only IgG hepatitis ...

  9. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression - Mayo Clinic

    Known infection with hepatitis B, hepatitis C, or HIV (Patients will be serologically screened prior to study entry (if the rest has been completed in the ...

  10. Immunotherapy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether INO-8000 alone or in combination with INO-9012 (IL-12) is safe and induces a Hepatitis C virus-specific immune ...